
Covid-19: WHO approves Chinese Sinovac vaccine for emergency use
India Today
The World Health Organization (WHO) has approved the Covid-19 vaccine made by Sinovac for emergency use. It is the second Chinese vaccine to be approved by the WHO after it gave a nod to Sinopharm’s Covid-19 vaccine for emergency use in early May.
The World Health Organization has issued an emergency use listing for the Covid-19 vaccine made by Sinovac in adults aged 18 and over, the second such authorisation it has granted to a Chinese company. In a statement Tuesday, the UN health agency said data submitted to its experts showed that two doses of the vaccine prevented people from getting symptoms of Covid-19 in about half of those who got the vaccine. WHO said there were few older adults enrolled in the research, so it could not estimate how effective the vaccine was in people over age 60. “Nevertheless, WHO is not recommending an upper age limit for the vaccine,” the agency said, adding that data collected from Sinovac’s use in other countries “suggest the vaccine is likely to have a protective effect in older persons.”
Legal immigration to the US in 2025 has seen one of its sharpest declines since the pandemic. About 2,50,000 fewer visas in total were issued compared to 2024, reported The Washington Post. The drop has been global, but India stands out as one of the worst affected, alongside China. Visa approvals for the two countries fell by a combined 84,000.

Oil and gas refineries and hubs are up in flames not just in the Middle East, but also in Russia and the US. Crude oil prices have surged over $100 a barrel. With the energy infrastructure in the Middle East likely to take years to be rebuilt, the world could be set for the biggest oil disruption in history.











